| Entry |
|
|---|
| Name |
Emapticap pegol (INN) |
|---|
| Formula |
C393H501N153O286P40[C2H4O]2n
|
|---|
| Efficacy |
Anti-inflammatory, Immunomodulator, CCL2 inhibitor |
|---|
| Type |
RNA aptamer |
|---|
| Comment |
Treatment of diabetic nephropathy
|
|---|
| Target |
|
|---|
| Pathway |
| hsa04060 | Cytokine-cytokine receptor interaction |
| hsa04933 | AGE-RAGE signaling pathway in diabetic complications |
|
|---|
| Brite |
Target-based classification of drugs [BR:br08310]
Cytokines and receptors
Cytokines
Chemokines
CCL2
D12654 Emapticap pegol (INN)
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
